GlassScriptPhysician profile
Daniel Lee Dasilva
NPI 1588977417
$892.34
in general payments reported to CMS, 2019-2025
6 companies · $69.13 in 2025
The $69.13 reported for 2025 was less than what a typical Vascular & Interventional Radiology provider received nationally (typical 2025 total: $537).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $223 · 2022: $155 · 2023: $14.01 · 2024: $431 · 2025: $69.13.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $489 · Travel and Lodging: $25.34.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $488.74 |
| Travel and Lodging | $25.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Trisalus Life Sciences, INC. | $326.26 | 2022-2025 | Trinav Infusion System |
| Boston Scientific Corporation | $249.17 | 2024 | Obsidio, Embold Fibered |
| Sirtex Medical INC | $141.77 | 2019 | |
| Medtronic USA, INC. | $81.53 | 2019 | |
| Medtronic, INC. | $79.60 | 2024-2025 | Pipeline, Osteocool Rf Ablation System |
| Bard Peripheral Vascular, INC. | $14.01 | 2023 | Pristine |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Dasilva listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.